Generated: May 28, 2017
|Title:||Composition comprising a tramadol material and acetaminophen and its use|
|Abstract:||This invention relates to a composition comprising a tramadol material and acetaminophen, and its use. As used herein tramadol refers to various forms of tramadol. The compositions are pharmacologically useful in treating pain and tussive conditions. The compositions are also subject to less opioid side-effects such as abuse liability, tolerance, constipation and respiratory depression. Furthermore, where the components of the compositions are within certain ratios the pharmacological effects of the compositions are superadditive (synergistic).|
|Inventor(s):||Raffa; Robert B. (Norristown, PA), Vaught; Jeffrey L. (Glenmoore, PA)|
|Assignee:||Ortho-McNeil Pharmaceutical, Inc. (Raritan, NJ)|
Patent Claim Types:|
see list of patent claims
|Composition; Use; Dosage form; Formulation;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||0566709||► Subscribe||91079||Luxembourg||► Subscribe|
|European Patent Office||0566709||► Subscribe||SPC/GB04/012||United Kingdom||► Subscribe|
|European Patent Office||0566709||► Subscribe||300152||Netherlands||► Subscribe|
|European Patent Office||0566709||► Subscribe||SPC023/2008||Ireland||► Subscribe|
|European Patent Office||0566709||► Subscribe||C300152||Netherlands||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.